Search Results - "BILLER, A"
-
1
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Published in Cell reports (Cambridge) (19-04-2016)“…Homozygous deletions of p16/CDKN2A are prevalent in cancer, and these mutations commonly involve co-deletion of adjacent genes, including methylthioadenosine…”
Get full text
Journal Article -
2
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Published in Science (American Association for the Advancement of Science) (03-05-2013)“…A number of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2). These mutations alter…”
Get full text
Journal Article -
3
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Published in Cancer cell (08-02-2021)“…The methylthioadenosine phosphorylase (MTAP) gene is located adjacent to the cyclin-dependent kinase inhibitor 2A (CDKN2A) tumor-suppressor gene and is…”
Get full text
Journal Article -
4
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Published in Science (American Association for the Advancement of Science) (03-05-2013)“…The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metabolism of cancer cells for cancer therapy. One…”
Get full text
Journal Article -
5
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Published in Cancer discovery (01-05-2017)“…Somatic gain-of-function mutations in isocitrate dehydrogenases ( ) 1 and 2 are found in multiple hematologic and solid tumors, leading to accumulation of the…”
Get more information
Journal Article -
6
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
Published in Nature (London) (01-07-2018)“…Somatic mutations in the isocitrate dehydrogenase 2 gene ( IDH2 ) contribute to the pathogenesis of acute myeloid leukaemia (AML) through the production of the…”
Get full text
Journal Article -
7
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase
Published in Nature communications (09-01-2019)“…Squalene epoxidase (SQLE), also known as squalene monooxygenase, catalyzes the stereospecific conversion of squalene to 2,3( S )-oxidosqualene, a key step in…”
Get full text
Journal Article -
8
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition
Published in Blood (08-01-2015)“…Mutations of IDH1 and IDH2, which produce the oncometabolite 2-hydroxyglutarate (2HG), have been identified in several tumors, including acute myeloid…”
Get full text
Journal Article -
9
Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
Published in Diabetes (New York, N.Y.) (01-06-2008)“…Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats Songping Han 1 , Deborah L. Hagan 1 , Joseph R. Taylor 1 ,…”
Get full text
Journal Article -
10
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma
Published in ACS medicinal chemistry letters (13-02-2020)“…Inhibitors of mutant isocitrate dehydrogenase (mIDH) 1 and 2 cancer-associated enzymes prevent the accumulation of the oncometabolite d-2-hydroxyglutarate…”
Get full text
Journal Article -
11
A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition
Published in Nature communications (09-01-2019)“…Aberrant metabolism of cancer cells is well appreciated, but the identification of cancer subsets with specific metabolic vulnerabilities remains challenging…”
Get full text
Journal Article -
12
Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
Published in Journal of medicinal chemistry (13-03-2008)“…The C-aryl glucoside 6 (dapagliflozin) was identified as a potent and selective hSGLT2 inhibitor which reduced blood glucose levels in a dose-dependent manner…”
Get full text
Journal Article -
13
Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Published in Journal of medicinal chemistry (28-07-2005)“…Efforts to further elucidate structure−activity relationships (SAR) within our previously disclosed series of β-quaternary amino acid linked…”
Get full text
Journal Article -
14
Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression
Published in American journal of neuroradiology : AJNR (01-01-2016)“…MR imaging in neuro-oncology is challenging due to inherent ambiguities in proton signal behavior. Sodium-MR imaging may substantially contribute to the…”
Get full text
Journal Article -
15
The Gemini Planet-Finding Campaign: The Frequency of Giant Planets Around Debris Disk Stars
Published in The Astrophysical journal (20-08-2013)“…We have completed a high-contrast direct imaging survey for giant planets around 57 debris disk stars as part of the Gemini NICI Planet-Finding Campaign. We…”
Get full text
Journal Article -
16
Constraints on Extrasolar Planet Populations from VLT NACO/SDI and MMT SDI and Direct Adaptive Optics Imaging Surveys: Giant Planets are Rare at Large Separations
Published in The Astrophysical journal (10-02-2008)“…We examine the implications for the distribution of extrasolar planets based on the null results from two of the largest direct imaging surveys published to…”
Get full text
Journal Article -
17
THE GEMINI NICI PLANET-FINDING CAMPAIGN: THE COMPANION DETECTION PIPELINE
Published in The Astrophysical journal (10-12-2013)“…We present high-contrast image processing techniques used by the Gemini NICI Planet-Finding Campaign to detect faint companions to bright stars. The…”
Get full text
Journal Article -
18
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB?
Published in Neurology (31-08-2010)Get full text
Journal Article -
19
The Gemini NICI Planet-finding Campaign: Discovery of a Substellar L Dwarf Companion to the Nearby Young M Dwarf CD–35 2722
Published in The Astrophysical journal (10-03-2011)“…We present the discovery of a wide (67 AU) substellar companion to the nearby (21 pc) young solar-metallicity M1 dwarf CD--35 2722, a member of the 100 Myr AB…”
Get full text
Journal Article -
20
Evidence Against an Edge-on Disk Around the Extrasolar Planet, 2MASS 1207 b and a New Thick-cloud Explanation for Its Underluminosity
Published in The Astrophysical journal (10-05-2011)“…Since the discovery of the first directly imaged, planetary-mass object, 2MASS 1207 b, several works have sought to explain a disparity between its observed…”
Get full text
Journal Article